ANYO Labs
G├╢teborg
About ANYO Labs
Revolutionize your drug discovery process with i-TripleD, the revolutionary Machine Learning software from ANYO Labs. Screen vast libraries of compounds in mere seconds and identify new drug candidates faster than ever before. ANYO Labs also aids biotech companies in ADMET property predictions, protein-protein interactions and utilises its immense speed in de novo generation of new small molecule compounds.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $472.0K
- Funding stage: Seed
- Last round: Seed (May 2024)
- Website: anyolabs.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/anyo-labs-135219 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.